RxSight, Inc. RXST
5.08 USD +0.49 (+10.68%)
Nov 4, 2026, 3:23 PM EST
4.11 Day range 5.45
4.11 52-week range 13.22
- YTD
- -51.25%
- 1 year
- -43.56%
Financial health
Altman Z-Score
-0.90 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C+2 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 5
Valuation
P/E -11.0×
FY 2019 5y median -11.0× FY 2025
P/S 3.2×
FY 2019 5y median 9.5× FY 2025
P/B 1.6×
FY 2019 5y median 3.9× FY 2025
P/FCF -22.2×
FY 2019 5y median -22.2× FY 2025
EV/EBITDA -11.8×
FY 2019 5y median -11.8× FY 2025
EV/Sales 3.1×
FY 2019 5y median 9.5× FY 2025
FCF Yield -4.5%
FY 2019 5y median -4.5% FY 2025
Profitability
Gross Margin 76.6%
FY 2019 5y median 60.4% FY 2025
Operating Margin -35.8%
FY 2019 5y median -56.2% FY 2025
Net Margin -29.0%
FY 2019 5y median -54.6% FY 2025
ROE -14.1%
FY 2019 5y median -30.3% FY 2025
ROIC -16.8%
FY 2019 5y median -28.8% FY 2025
ROA -12.5%
FY 2019 5y median -25.3% FY 2025
Growth (YoY)
Revenue -3.9%
FY 2019 FY 2025
Operating Income -30.7%
FY 2019 FY 2025
EPS (diluted) -33.8%
FY 2019 FY 2025
Free Cash Flow 13.6%
FY 2019 FY 2025
Financial Health
Current Ratio 10.9×
FY 2019 5y median 10.9× FY 2025
Quick Ratio 9.7×
FY 2019 5y median 9.7× FY 2025
Debt / Equity 0.0×
FY 2019 5y median 0.0× FY 2025
Net Debt / EBITDA 0.3×
FY 2019 5y median 0.2× FY 2025
Interest Coverage -1205×
FY 2019 5y median -15.1× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31